AMD: Untreated Sleep Apnea May Reduce Response to BevacizumabAMD: Untreated Sleep Apnea May Reduce Response to Bevacizumab
A small, single-center study has suggested untreated sleep apnea reduces treatment response to bevacizumab in patients with exudative age-related macular degeneration. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology News Source Type: news
More News: Age-Related Macular Degeneration (AMD) | Avastin | Health | Opthalmology | Sleep Apnea | Sleep Disorders | Sleep Medicine | Study